Cyclorasin 9A5 incorporates a cyclic peptide scaffold engineered to explore protein-protein interaction motifs. The conformational constraints enhance stability and binding selectivity. Researchers assess its structural rigidity and solvent-dependent behavior. Applications include therapeutic-mimic design, conformational studies, and ligand-optimization research.
CAT No: R2675
CAS No:1782098-79-6
Synonyms/Alias:Cyclorasin 9A5;CHEMBL4870310;HY-P10051;DA-52238;CS-0905163;1782098-79-6;
Cyclorasin 9A5 is a synthetic cyclic peptide recognized for its unique structure and valuable properties in biochemical research. The macrocyclic conformation of Cyclorasin 9A5 imparts remarkable stability and resistance to enzymatic degradation, making it a preferred tool for studying protein-protein interactions. Its sequence and cyclization are specifically engineered to enable high-affinity binding to target proteins, which has propelled its use in various molecular biology and drug discovery applications. Researchers appreciate Cyclorasin 9A5 for its ability to mimic bioactive conformations, facilitating the exploration of complex biological pathways and the modulation of intracellular signaling cascades. The versatility and robustness of this cyclic peptide have established it as a critical reagent in the toolkit of chemical biology and structural biology laboratories.
Protein-Protein Interaction Inhibition: Cyclorasin 9A5 has gained significant attention for its application in disrupting protein-protein interactions, especially those implicated in disease-related signaling pathways. By binding to specific domains on target proteins, the peptide can competitively inhibit the formation of protein complexes, thereby modulating downstream biological effects. This mechanism is instrumental in basic research aimed at elucidating the roles of transient protein assemblies in cellular processes, providing insights into the molecular underpinnings of cell signaling and regulation. The use of Cyclorasin 9A5 in these studies enables researchers to dissect the contributions of individual protein interfaces with high specificity and temporal control.
Target Validation in Drug Discovery: In the context of early-stage drug discovery, Cyclorasin 9A5 serves as a valuable probe for target validation. Its ability to selectively bind and modulate protein function allows scientists to confirm the biological relevance of specific targets before investing in the development of small-molecule inhibitors. By employing Cyclorasin 9A5 in cellular or biochemical assays, researchers can assess the phenotypic consequences of target inhibition, thus streamlining the identification of promising therapeutic avenues. This application highlights the peptide's role in bridging the gap between target identification and lead optimization, accelerating the overall drug discovery process.
Structural Biology and Biophysical Characterization: The robust and well-defined structure of Cyclorasin 9A5 makes it an ideal candidate for structural biology studies, including X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy. Its resistance to proteolytic degradation ensures that it remains intact during experimental procedures, allowing for high-resolution characterization of peptide-protein complexes. These structural insights are invaluable for mapping binding interfaces, understanding conformational dynamics, and guiding the rational design of improved analogs or inhibitors. The use of Cyclorasin 9A5 in biophysical assays also supports the quantitative analysis of binding kinetics and thermodynamics, further enriching the understanding of molecular recognition events.
Cellular Pathway Modulation: Researchers utilize Cyclorasin 9A5 to probe and manipulate intracellular signaling pathways. Its cell-permeable properties enable it to access cytosolic targets and interfere with signaling cascades at the molecular level. By selectively modulating the activity of key signaling proteins, the peptide provides a means to study the functional consequences of pathway perturbation in a controlled manner. This application is particularly valuable for unraveling the complexity of cellular responses to external stimuli, mapping network connectivity, and identifying potential intervention points for therapeutic development.
Chemical Biology Tool Development: Cyclorasin 9A5 is frequently employed as a scaffold for the development of novel chemical biology tools. Its stable cyclic backbone serves as a platform for the incorporation of functional groups, fluorescent tags, or affinity labels, expanding its utility in a variety of experimental settings. By customizing the peptide for specific research needs, scientists can generate tailored probes for imaging, target enrichment, or functional screening. This adaptability underscores the importance of Cyclorasin 9A5 in advancing the frontiers of chemical biology and enabling innovative approaches to molecular interrogation.
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
2. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
4. Emu oil in combination with other active ingredients for treating skin imperfections
5. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More